Donald R Hoffman1, Rhonda H Sakell, Margit Schmidt. 1. Department of Pathology and Laboratory Medicine, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA. hoffmand@mail.ecu.edu
Abstract
BACKGROUND: Sol i 1, the venom phospholipase of imported fire ant venom is an important allergen and exhibits some cross-reactivity with IgE antibodies from patients sensitized to other Hymenoptera venoms. OBJECTIVE: To determine the primary structure of Sol i 1 and evaluate the roles of protein and carbohydrate epitopes in its cross-reactivity. METHODS: Sol i 1 was purified from venom, proteolytic peptides prepared and amino acid sequences obtained. The cDNA for Sol i 1 was cloned, sequenced, and compared with sequences of other wasp venom phospholipases. The role of carbohydrate epitopes in the cross-reactivity with other Hymenoptera venoms was studied by RAST inhibition. RESULTS: The sequence identified Sol i 1 as a lipase of the GX class, lipoprotein lipase superfamily, pancreatic lipase homologous family and RP2 subgroup phospholipases as are the vespid venom phospholipases. The 148 residues identified by amino acid sequencing represent about 48% of the translated cDNA sequence. Sol i 1 was 31-32% identical to yellow jacket phospholipases. The identical regions of sequence were clustered in the domain which forms the serine hydrolase active site. Mannosylated N-glycans could completely inhibit binding of IgE from honeybee venom sensitized patients to Sol i 1. Inhibition by glycan of IgE binding from yellow jacket venom sensitized patients was low or absent for three of eight sera and substantial, but not complete for five sera. CONCLUSIONS: Sol i 1 is related to wasp venom phospholipases. Cross-reactivity with honeybee venom is caused by carbohydrate, whereas cross-reactivity with yellow jacket venom involves reactivity with both carbohydrate determinants of hyaluronidase and high molecular weight proteins and phospholipase protein determinants.
BACKGROUND: Sol i 1, the venom phospholipase of imported fire ant venom is an important allergen and exhibits some cross-reactivity with IgE antibodies from patients sensitized to other Hymenoptera venoms. OBJECTIVE: To determine the primary structure of Sol i 1 and evaluate the roles of protein and carbohydrate epitopes in its cross-reactivity. METHODS: Sol i 1 was purified from venom, proteolytic peptides prepared and amino acid sequences obtained. The cDNA for Sol i 1 was cloned, sequenced, and compared with sequences of other wasp venom phospholipases. The role of carbohydrate epitopes in the cross-reactivity with other Hymenoptera venoms was studied by RAST inhibition. RESULTS: The sequence identified Sol i 1 as a lipase of the GX class, lipoprotein lipase superfamily, pancreatic lipase homologous family and RP2 subgroup phospholipases as are the vespid venom phospholipases. The 148 residues identified by amino acid sequencing represent about 48% of the translated cDNA sequence. Sol i 1 was 31-32% identical to yellow jacket phospholipases. The identical regions of sequence were clustered in the domain which forms the serine hydrolase active site. Mannosylated N-glycans could completely inhibit binding of IgE from honeybee venom sensitized patients to Sol i 1. Inhibition by glycan of IgE binding from yellow jacket venom sensitized patients was low or absent for three of eight sera and substantial, but not complete for five sera. CONCLUSIONS: Sol i 1 is related to wasp venom phospholipases. Cross-reactivity with honeybee venom is caused by carbohydrate, whereas cross-reactivity with yellow jacket venom involves reactivity with both carbohydrate determinants of hyaluronidase and high molecular weight proteins and phospholipase protein determinants.
Authors: Dubravko Rendić; Jaroslav Klaudiny; Ute Stemmer; Julia Schmidt; Katharina Paschinger; Iain B H Wilson Journal: Biochem J Date: 2007-02-15 Impact factor: 3.857
Authors: Jeffrey M Wilson; Behnam Keshavarz; Maya Retterer; Lisa J Workman; Alexander J Schuyler; Emily C McGowan; Charles Lane; Alaaddin Kandeel; Jane Purser; Eva Rönmark; Joseph LaRussa; Scott P Commins; Tina Merritt; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2020-06-06 Impact factor: 10.793
Authors: Troy Wanandy; Emily Mulcahy; Wun Yee Lau; Simon G A Brown; Michael D Wiese Journal: Clin Rev Allergy Immunol Date: 2021-06-01 Impact factor: 8.667
Authors: Alba F C Torres; Chen Huang; Cheong-Meng Chong; Siu Wai Leung; Alvaro R B Prieto-da-Silva; Alexandre Havt; Yves P Quinet; Alice M C Martins; Simon M Y Lee; Gandhi Rádis-Baptista Journal: PLoS One Date: 2014-01-31 Impact factor: 3.240
Authors: Wallace Felipe Blohem Pessoa; Ludimilla Carvalho Cerqueira Silva; Leila de Oliveira Dias; Jacques Hubert Charles Delabie; Helena Costa; Carla Cristina Romano Journal: Int J Mol Sci Date: 2016-04-21 Impact factor: 5.923